Back to 
Polar Capital Holdings Plc
Polar Capital Holdings Plc
ALLO
Showing 0 of 2 quarters
Position history for Polar Capital Holdings Plc's holdings in Allogene Therapeutics, Inc.
No. Polar Capital Holdings exited its ALLO (Allogene Therapeutics) position in Q1 2021. Its Q4 2020 13F listed 251,473 shares worth $6.3M. Polar Capital Holdings already held ALLO in its Q4 2020 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.